The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis
Open accessAbstract
Extensive research causally links amyloid-beta peptide (A beta) to Alzheimer's disease, although the pathologically relevant A beta conformation remains unclear. A beta spontaneously aggregates into the fibrils that deposit in senile plaques. However, recent in vivo and in vitro reports describe a potent biological activity for oligomeric assemblies of A beta. To consistently prepare in vitro oligomeric and fibrillar forms of A beta 1-42, a detailed knowledge of how solution parameters influence structure is required. This manuscript represents the first study using a single chemically and structurally homogeneous unaggregated starting material to demonstrate that the formation of oligomers, fibrils, and fibrillar aggregates is determined by time, concentration, temperature, pH, ionic strength, and A beta species. We recently reported that oligomers inhibit neuronal viability 10-fold more than fibrils and approximately 40-fold more than unaggregated peptide, with oligomeric A beta 1-42-induced neurotoxicity significant at 10 nm. In addition, we were able to differentiate by structure and neurotoxic activity wild-type A beta1-42 from isoforms containing familial mutations (Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) J. Biol. Chem. 277, 32046-32053). Understanding the biological role of specific A beta conformations may define the link between A beta and Alzheimer's disease, re-focusing therapeutic approaches by identifying the pernicious species of A beta ultimately responsible for the cognitive dysfunction that defines the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The 48 h total incubation leads to mature Aβ42 fibrils, as observed by TEM (Figure 10, panel a) while the Western blot shows the presence of higher order Aβ42 oligomers (Figure 10, lane a), likely due to an assembly-disassembly equilibrium that is established for mature Aβ fibrils.89–91”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [91]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, the MOAB-2-based oA42 ELISA detects oligomeric but not monomeric A42 using synthetic preparations characterized previously by our laboratory (data not shown) (47,48).”
From APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease (2012) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citationImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,559
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Flagged first, then by citations
Research works printed but not linked: 3
- Hou, 2002, J. Biol. Chem., 26, 26
- DePace, 2002, Nat. Struct. Biol., 9, 389
- Fezoui, 2002, J. Biol. Chem., 30, 30
Cited by
Sorted by citations
Items 501–600 of 999
Improving the inhibition of β-amyloid aggregation by withanolide and withanoside derivatives
Dubey, S., Kallubai, M., & Subramanyam, R. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.094 · Cited by 29
Lambert, M., Velasco, P., Viola, K., & Klein, W. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601876 · Cited by 29
Yoshihara, T., Takiguchi, S., Kyuno, A., Tanaka, K., Kuba, S., Hashiguchi, S., Ito, Y., Hashimoto, T., Iwatsubo, T., Tsuyama, S., et al. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm239 · Cited by 29
Amyloid‐β Aggregation with Gold Nanoparticles on Brain Lipid Bilayer
Lee, H., Kim, Y., Park, A., & Nam, J. (2014) · Small · doi:10.1002/smll.201303242 · Cited by 29
Li, Y., Lu, J. N., Cao, X., Zhao, H., Gao, L., Xia, P., & Pei, G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7698560 · Cited by 29
Hettmann, T., Gillies, S. D., Kleinschmidt, M., Piechotta, A., Makioka, K., Lemere, C. A., Schilling, S., Rahfeld, J., & Lues, I. (2020) · Scientific Reports · doi:10.1038/s41598-020-60319-5 · Cited by 29
Microglia show differential transcriptomic response to Aβ peptide aggregates ex vivo and in vivo
McFarland, K. N., Ceballos, C., Rosario, A. M., Ladd, T. B., Moore, B. D., Golde, G., Wang, X., Allen, M., Ertekin‐Taner, N., Funk, C. C., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202101108 · Cited by 31
Legleiter, J. A., Fryer, J. D., Holtzman, D. M., & Kowalewski, T. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn2000475 · Cited by 28
N-terminal Domain of Myelin Basic Protein Inhibits Amyloid β-Protein Fibril Assembly
Liao, M.-C., Hoos, M. D., Aucoin, D., Ahmed, M., Davis, J., Smith, S. O., & Nostrand, W. E. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169599 · Cited by 29
Different Fates of Alzheimer’s Disease Amyloid-β Fibrils Remodeled by Biocompatible Small Molecules
Irwin, J. A., Wong, H. E., & Kwon, I. (2012) · Biomacromolecules · doi:10.1021/bm3016994 · Cited by 29
Sohma, Y., Taniguchi, A., Yoshiya, T., Chiyomori, Y., Fukao, F., Nakamura, S., Skwarczyński, M., Okada, T., Ikeda, K., Hayashi, Y., et al. (2006) · Journal of Peptide Science · doi:10.1002/psc.817 · Cited by 30
Asam, K. R., Staniszewski, A., Zhang, H., Melideo, S. L., Mazzeo, A., Voronkov, M. V., Huber, K. L., Pérez, E., Stock, M. B., Stock, J. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189413 · Cited by 28
Caneus, J., Akanda, N., Rumsey, J. W., Guo, X., Jackson, M., Long, C. J., Sommerhage, F., Georgieva, S., Kanaan, N. M., Morgan, D., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12029 · Cited by 29
Epelbaum, S., Youssef, I., Lacor, P. N., Chaurand, P., Duplus, E., Brugg, B., Duyckaerts, C. J., & Delatour, B. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.005 · Cited by 30
Reinke, A. A., Seh, H. Y., & Gestwicki, J. E. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.082 · Cited by 26
Janssen, L., Sobott, F., Deyn, P. P. D., & Dam, D. V. (2015) · MethodsX · doi:10.1016/j.mex.2015.02.011 · Cited by 27
Monitoring the earliest amyloid-β oligomers via quantized photobleaching of dye-labeled peptides
Dukes, K. D., Rodenberg, C. F., & Lammi, R. K. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.07.011 · Cited by 27
Nitration of Tyrosine Residue Y10 of Aβ1–42 Significantly Inhibits Its Aggregation and Cytotoxicity
Zhao, J. J., Wu, J., Yang, Z., Li, H., & Gao, Z. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00447 · Cited by 28
Kilinc, D., Vreulx, A.-C., Mendes, T., Flaig, A., Coelho, D. M., Verschoore, M., Demiautte, F., Amouyel, P., Bank, N.-C. B., Eysert, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa139 · Cited by 34
Shimada, M., Abe, S., Takahashi, T., Shiozaki, K., Okuda, M., Mizukami, H., Klinman, D. M., Ozawa, K., & Okuda, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057606 · Cited by 27
Role of Small Oligomers on the Amyloidogenic Aggregation Free-Energy Landscape
He, X., Giurleo, J. T., & Talaga, D. S. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.10.019 · Cited by 26
Chang, L., Zhang, Y., Liu, J., Song, Y., Lv, A., Li, Y., Zhou, W., Yan, Z., Almeida, O. F. X., & Wu, Y. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150942 · Cited by 27
Localized molecular chaperone synthesis maintains neuronal dendrite proteostasis
Alecki, C., Rizwan, J., Le, P., Jacob‐Tomas, S., Comaduran, M. F., Verbrugghe, M., Xu, J. M. S., Minotti, S., Lynch, J., Biswas, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-55055-7 · Cited by 26
Chemical Chaperone and Inhibitor Discovery: Potential Treatments for Protein Conformational Diseases
Zhao, J., Liu, H., Lin, H., Huang, C., Fang, H., Chen, S., Ho, Y., Tsai, W., & Chen, W. (2007) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s212 · Cited by 26
Amyloid A β 42 , a promoter of magnetite nanoparticle formation in Alzheimer’s disease
Tahirbegi, I. B., Pardo, W. A., Alvira, M., Mir, M., & Samitier, J. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/46/465102 · Cited by 26
Hayden, E. Y., Conovaloff, J., Mason, A. J., Bitan, G., & Teplow, D. B. (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2016.10.026 · Cited by 26
Yates, E. A., & Legleiter, J. A. (2014) · Biochemistry · doi:10.1021/bi500792f · Cited by 26
Rojas, A. V., Maisuradze, G. G., & Scheraga, H. A. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b04647 · Cited by 28
Wang, X., Gu, X., Li, L., Yu, B., Lv, L., Chen, Q., & Xu, M. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03319-2 · Cited by 26
Effects of Tissue Transglutaminase on β -Amyloid1-42-Induced Apoptosis
Wakshlag, J. J., Antonyak, M. A., Boehm, J. E., Boehm, K., & Cerione, R. A. (2006) · The Protein Journal · doi:10.1007/s10930-006-0009-1 · Cited by 26
Vestergaard, M. C. M., Hamada, T., Saito, M., Yajima, Y., Kudou, M., Tamiya, E., & Takagi, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.072 · Cited by 26
Hao, J., Zhang, W., Zhang, P., Liu, R., Liu, L., Lei, G., Su, C., Miao, J., & Li, Z. (2010) · Neuropeptides · doi:10.1016/j.npep.2010.03.001 · Cited by 26
Monitoring Insulin Aggregation via Capillary Electrophoresis
Pryor, E. N., Kotarek, J. A., Moss, M. A., & Hestekin, C. N. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129369 · Cited by 28
Cisternas, P., Zolezzi, J. M., Lindsay, C. B., Rivera, D. S., Martinez, A. N., Bozinovic, F., & Inestrosa, N. C. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180729 · Cited by 27
Srivastava, A. K., Choudhury, S. R., & Karmakar, S. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22214 · Cited by 26
A 13 kDa carboxy‐terminal fragment of ApoE stabilizes Abeta hexamers
Wellnitz, S., Friedlein, A., Bonanni, C., Anquez, V., Goepfert, F., Loetscher, H., Adessi, C., & Czech, C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03295.x · Cited by 26
Darricau, M., Dou, C., Kinet, R., Zhu, T., Zhou, L., Li, X., Bedel, A., Claverol, S., Tokarski, C., Katsinelos, T., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13604 · Cited by 30
Fulcher, J. M., Ives, A. N., Tasaki, S., Kelly, S. S., Williams, S., Fillmore, T., Zhou, M., Moore, R., Qian, W., Paša‐Tolić, L., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100983 · Cited by 25
Guo, J., Yu, L., Sun, Y. P., & Dong, X. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b12187 · Cited by 25
Fullerenemalonates inhibit amyloid beta aggregation, in vitro and in silico evaluation
Martínez‐Herrera, M., Figueroa-Gerstenmaier, S., García‐Sierra, F., Beltrán, H. I., Rivera-Fernández, N., Romero, J. A. L., López-Camacho, P. Y., & Basurto‐Islas, G. (2018) · RSC Advances · doi:10.1039/c8ra07643j · Cited by 27
Zheng, M., Liu, Z., Mana, L., Qin, G., Huang, S., Gong, Z., Tian, M., He, Y., & Wang, P. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114264 · Cited by 25
Charged surfactants induce a non‐fibrillar aggregation pathway of amyloid‐beta peptide
Loureiro, J., Rocha, S., & Pereira, M. D. C. (2013) · Journal of Peptide Science · doi:10.1002/psc.2535 · Cited by 24
Towards Ratiometric Sensing of Amyloid Fibrils In Vitro
Freire, S., Rodríguez‐Prieto, F., Rodríguez, M. C. R., Penedo, J. C., Al‐Soufi, W., & Novo, M. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201406110 · Cited by 25
C-Terminal Threonine Reduces Aβ43 Amyloidogenicity Compared with Aβ42
Chemuru, S., Kodali, R. B., & Wetzel, R. B. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.06.008 · Cited by 25
Reddy, S. M. M., & Shanmugam, G. (2016) · ChemPhysChem · doi:10.1002/cphc.201600364 · Cited by 25
Chao, A., Chen, C.-H., Chang, S.-H., Huang, C.-T., Hwang, W., & Yang, D. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1098-5 · Cited by 25
Szegő, É. M., Csorba, A., Janáky, T., Kékesi, K. A., Ábrahám, I. M., Mórotz, G. M., Penke, B., Palkovits, M., Murvai, Ü., Kellermayer, M. S. Z., et al. (2011) · Neuroendocrinology · doi:10.1159/000321119 · Cited by 24
Δ133p53α Protects Human Astrocytes from Amyloid-beta Induced Senescence and Neurotoxicity
Ungerleider, K., Beck, J. A., Lissa, D., Joruiz, S. M., Horikawa, I., & Harris, C. C. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2022.06.004 · Cited by 24
Age-related p53 SUMOylation accelerates senescence and tau pathology in Alzheimer’s disease
Wan, L., Yang, F., Yin, A., Luo, Y., Yi, L. I. U., Liu, F., Wang, J., Liu, R., & Wang, X. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01448-0 · Cited by 26
Exogenous Aβ1-42 monomers improve synaptic and cognitive function in Alzheimer's disease model mice
Duan, Y., Lv, J., Zhang, Z., Chen, Z., Wu, H., Chen, J., Chen, Z., Yang, J., Wang, D., Liu, Y., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109002 · Cited by 24
N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer’s pathophysiology
Rostagno, A. A., Cabrera, E., Lashley, T., & Ghiso, J. A. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00303-3 · Cited by 23
Yu, Y., Zhang, L., Sun, X., Li, C., Qiu, Y., Sun, H.-P., Tang, D., Liu, Y., & Yin, X. (2015) · Chemical Communications · doi:10.1039/c5cc01855b · Cited by 24
A New Amyloid-Like β-Aggregate with Amyloid Characteristics, Except Fibril Morphology
Chang, E. S. ‐., Liao, T., Lim, T., Fann, W. S., & Chen, R. P. ‐. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.11.009 · Cited by 24
Liu, Y.-H., Lee, C., Chen, L., Lee, T.-L., Hsieh, Y.-Y., Han, C.-H., Yang, C.-H., Huang, W., & Hou, W. (2020) · Food & Function · doi:10.1039/c9fo02339a · Cited by 26
Frackowiak, J., Potempska, A., & Mazur‐Kolecka, B. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0497-0 · Cited by 24
Glossopharyngeal and vagal neuralgia secondary to vascular compression of the nerves.
Morales-Zavala, F., Albert, P., Alberca, R., de Valle, B., & Narros, A. (1977) · PubMed · Cited by 24
Efficient amyloid-β degradation in Alzheimer’s disease using SPYTACs
Teng, F., Liu, J., Cui, T., Tan, X., Liu, K., Hou, Z., (54356), L. Z., Xie, Y., Li, R., Li, D., et al. (2026) · Cell · doi:10.1016/j.cell.2026.01.034 · Cited by 25
Copper Ion Uptake by Chitosan in the Presence of Amyloid-β and Histidine
Mahl, C. R. A., Taketa, T. B., Neto, J. B. M. R., Almeida, W. P., & Beppu, M. M. (2019) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-019-03120-z · Cited by 23
Tan, X., Guan, H., Yang, Y., Luo, S., Hou, L., Chen, H., & Li, J. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115090 · Cited by 23
Olajide, O. J., Rue, C. L., Bergdahl, A., & Chapman, C. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.960314 · Cited by 24
Chen, S., Wu, C., Lin, T., Chuang, Y., & Yang, D. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.012 · Cited by 23
Křı́ž, Z., Klusák, J., Krištofíková, Z., & Koča, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062914 · Cited by 23
Lim, K. H., Henderson, G. L., Jha, A., & Louhivuori, M. (2007) · ChemBioChem · doi:10.1002/cbic.200700194 · Cited by 23
Mikhalyov, I. I., Olofsson, A., Gröbner, G., & Johansson, L. B. ‐. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.06.043 · Cited by 23
Todd, K. L., Ghiso, J. A., & Rostagno, A. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.003 · Cited by 22
Kimura, R., MacTavish, D., Yang, J., Westaway, D. A., & Jhamandas, J. H. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9684-x · Cited by 24
Pierucci, F., Garcia‐Gil, M., Frati, A., Bini, F., Martinesi, M., Vannini, E., Mainardi, M., Luzzati, F., Peretto, P. M., Caleo, M., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.003 · Cited by 24
Cazzaniga, E., Bulbarelli, A., Lonati, E., Orlando, A., Re, F., Gregori, M., & Masserini, M. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0415-4 · Cited by 23
Hahm, E.-T., Nagaraja, R. Y., Waro, G., & Tsunoda, S. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.029 · Cited by 24
Yu, Y., Zhang, L., Li, C., Sun, X., Tang, D., & Shi, G. (2014) · Angewandte Chemie · doi:10.1002/ange.201405001 · Cited by 23
Scheinost, J. C., Wang, H., Boldt, G. E., Offer, J., & Wentworth, P. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705922 · Cited by 23
Globular and Protofibrillar Aβ Aggregates Impair Neurotransmission by Different Mechanisms
Moreth, J., Kroker, K. S., Schwanzar, D., Schnack, C., Arnim, C. A. F. V., Hengerer, B., Rosenbrock, H., & Kußmaul, L. (2013) · Biochemistry · doi:10.1021/bi3016444 · Cited by 24
Sakata, R. P., Antoniolli, G., Lancellotti, M., Kawano, D. F., Barbosa, E. G., & Almeida, W. P. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104201 · Cited by 22
Antonino, M., Marmo, P., Freites, C. L., Quassollo, G., Sánchez, M. F., Lorenzo, A., & Bignante, E. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.852738 · Cited by 24
Mizutani, H., Sato, Y., Yamazaki, M., Yoshizawa, T., Ando, Y., Ueda, M., & Yamagata, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169027 · Cited by 22
Amyloid-β Activates Microglia and Regulates Protein Expression in a Manner Similar to Prions
Tu, J., Chen, B., Yang, L., Qi, K., Lu, J. N., & Zhao, D. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0553-2 · Cited by 23
Isolating Toxic Insulin Amyloid Reactive Species that Lack β-Sheets and Have Wide pH Stability
Heldt, C. L., Kurouski, D., Sorci, M., Grafeld, E., Lednev, I. K., & Belfort, G. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.04.046 · Cited by 22
Orbán, G., Völgyi, K., Juhász, G. D., Penke, B., Kékesi, K. A., Kardos, J., & Czurkó, A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.061 · Cited by 22
Labour, M.-N., Vigier, S., Lerner, D. A., Marcilhac, A., & Belamie, E. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.04.001 · Cited by 22
Antibody blood-brain barrier efflux is modulated by glycan modification
Finke, J. M., Ayres, K. R., Brisbin, R., Hill, H. A., Wing, E. E., & Banks, W. A. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.06.008 · Cited by 22
Alzheimer’s Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail
Chang, Y., Nguyen, H. L., Shih, Y., Yu, H., Li, M. S., & Chen, Y. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00049 · Cited by 22
Zhang, Z., Lv, M., Liu, Y., Qin, J., Fan, Z., & Du, J. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202401208 · Cited by 21
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 21
Oligomeric Forms of Human Amyloid-Beta(1–42) Inhibit Antigen Presentation
Gericke, C., Mallone, A., Engelhardt, B., Nitsch, R. M., & Ferretti, M. T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01029 · Cited by 20
Said, M. S., Navale, G. R., Yadav, A., Khonde, N. S., Shinde, S. S., & Jha, A. (2020) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106480 · Cited by 21
Singh, S., Navale, G. R., Agrawal, S., Singh, H. K., Singla, L., Sarkar, D. M., Sarma, M., Choudhury, A. R., & Ghosh, K. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124197 · Cited by 22
Murakami, K., Uno, M., Masuda, Y., Shimizu, T., Shirasawa, T., & Irie, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.009 · Cited by 22
Abraham, J. N., Kedracki, D., Prado, É., Gourmel, C., Maroni, P., & Nardin, C. (2014) · Biomacromolecules · doi:10.1021/bm501004q · Cited by 21
Amaro, M., Kubiak-Ossowska, K., Birch, D. J. S., & Rolinski, O. J. (2013) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/1/1/015006 · Cited by 21
Role and regulation of p27 in neuronal apoptosis
Jaiswal, S., & Sharma, P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13918 · Cited by 21
Supraja, P., Tripathy, S., Vanjari, S. R. K., Singh, R., Singh, V., & Singh, S. G. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130522 · Cited by 21
Self-Assembly of Aβ40, Aβ42 and Aβ43 Peptides in Aqueous Mixtures of Fluorinated Alcohols
Pachahara, S. K., Adicherla, H., & Nagaraj, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136567 · Cited by 21
Hung, Y.-H., Chang, S.-H., Huang, C.-T., Yin, J., Hwang, C., Yang, L., & Yang, D. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9046-5 · Cited by 21
Goldblatt, G., Cilenti, L., Matos, J. O., Lee, B., Ciaffone, N., Wang, Q. X., Tétard, L., Teter, K., & Tatulian, S. A. (2017) · FEBS Journal · doi:10.1111/febs.14058 · Cited by 21
Goldblatt, G., Matos, J. O., Gornto, J., & Tatulian, S. A. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp03343h · Cited by 20
Han, X., Ma, Y., Liu, X., Wang, L., Qi, S., Zhang, Q., & Du, Y. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0803-1 · Cited by 20
Baringer, S. L., Lukacher, A. S., Palsa, K., Kim, H., Lippmann, E. S., Spiegelman, V. S., Simpson, I. A., & Connor, J. R. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15954 · Cited by 21
Understanding protein folding from globular to amyloid state
Amani, S., & Naeem, A. (2013) · Process Biochemistry · doi:10.1016/j.procbio.2013.08.011 · Cited by 21
Point Mutations in Aβ Induce Polymorphic Aggregates at Liquid/Solid Interfaces
Yates, E. A., Cucco, E. M., & Legleiter, J. A. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200001k · Cited by 20
Turano, E., Busetto, G., Marconi, S., Guzzo, F., Farinazzo, A., Commisso, M., Bistaffa, E., Angiari, S., Musumeci, S., Sotgiu, S., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.033 · Cited by 20
Metadata
- Authors
- Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J.
- Affiliations
- Northwestern University (US)
- Corresponding author
- LaDu, Mary Jo
- ORCID
- LaDu, Mary Jo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 13
- Pages
- 11612-11622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2133631618
- Cited by
- 1,015
- References
- 74
- Citations by year
- 2026: 40 · 2025: 39 · 2024: 37 · 2023: 39 · 2022: 34 · 2021: 49 · 2020: 37 · 2019: 40 · 2018: 33 · 2017: 46 · 2016: 49 · 2015: 42 · 2014: 60 · 2013: 52 · 2012: 69
- FWCI
- 19.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- Northwestern University
- National Institutes of Health (1p01ag015501-01, 5r01ag013496-05)
- National Institute on Aging (R01AG019121, AG-15501, AG 19121, AG13496)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, amyloid-beta 42, oligomerization, fibril formation, Alzheimer's disease, neurotoxicity, peptide aggregation, solution conditions, familial Alzheimer's disease mutations, amyloid plaques, peptide conformation
- MeSH terms
- Biopolymers, Circular Dichroism, Electrophoresis, Polyacrylamide Gel, Peptide Fragments, Solubility, Blotting, Western, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review